Esther Rajavelu - Jan 3, 2022 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Chief Financial Officer
Signature
/s/ Peter Thomson, as attorney-in-fact for Esther Rajavelu
Stock symbol
FULC
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/10/2022, 03:30 PM
Next filing
Feb 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +200K $0.00 200K Jan 3, 2022 Common Stock 200K $17.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on January 3, 2022 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of January 3, 2022. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.